Skip to main
SLGL

Sol-Gel Technologies (SLGL) Stock Forecast & Price Target

Sol-Gel Technologies (SLGL) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Sol-Gel Technologies Ltd has demonstrated a promising financial outlook, highlighted by a significant increase in projected peak annual sales for its products, as the anticipated pricing per patient has risen from $150K to $250K. The company’s lead product candidate, SGT-610, has the potential to generate over $300 million in annual revenue if approved, which positions it positively within the dermatology market, specifically for Gorlin syndrome patients. Additionally, the current valuation assessment does not factor in potential revenue from SGT-610 in high-frequency basal cell carcinoma indications, suggesting further substantial growth opportunities in the future.

Bears say

The negative outlook on Sol-Gel Technologies's stock stems from significant risks tied to its product pipeline, particularly the pivotal trial of SGT-610 for Gorlin syndrome, which may fail to yield positive results and secure U.S. regulatory approval. Furthermore, the discontinuation of the SGT-210 program for Darier disease highlights potential setbacks that could impede overall growth and market confidence. Additionally, the company's recent 1-for-10 reverse stock split raises concerns about possible medium- to long-term dilution risk, further complicating its financial stability and investor sentiment.

Sol-Gel Technologies (SLGL) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sol-Gel Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sol-Gel Technologies (SLGL) Forecast

Analysts have given Sol-Gel Technologies (SLGL) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Sol-Gel Technologies (SLGL) has a Strong Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sol-Gel Technologies (SLGL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.